Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Armbrust American is a private U.S. manufacturer of medical-grade masks, respirators, and related personal protective equipment. The company was launched in 2020 to rebuild domestic PPE manufacturing capacity and markets USA-made surgical masks, KN95 and N95 respirators, elastomeric masks, gloves, and filtration products. Its operations are centered in Texas, with an emphasis on vertical integration, American sourcing, and compliance for healthcare, government, and consumer customers. The business appears to be primarily a commercial-stage manufacturer and brand rather than a therapeutics developer, with no drug pipeline or clinical-stage assets. Armbrust has also expanded beyond disposable masks into reusable respiratory protection and home air filtration products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Armbrust American.